SCHEMBL31258862

SCHEMBL31258862

CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(CO)COC(=O)CCCCCC(=O)OCC(CCCC)CCCCCC

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.64
DGKA P23743 1/20 0.63
PRKCA P17252 2/20 0.60
PRKCE Q02156 1/20 0.60
PRKCQ Q04759 1/20 0.60
PRKCD Q05655 1/20 0.60
MGLL Q99685 1/20 0.55
CYP3A4 P08684 1/20 0.55
TSHR P16473 1/20 0.55
ATM Q13315 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
CNR1 P21554 2/20 0.54
CNR2 P34972 2/20 0.54
ALDH1A1 P00352 1/20 0.54
MAPT P10636 1/20 0.54
HPGD P15428 1/20 0.54
SELP P16109 1/20 0.53
S1PR1 P21453 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31462392 1.00 FAAH (0.64) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL31258951 0.98 FAAH (0.64) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL22602335 0.96 FAAH (0.65) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL22602555 0.95 FAAH (0.64) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL10786701 0.94 FAAH (0.64) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL10786331 0.94 FAAH (0.64) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL16826380 0.94 FAAH (0.71) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL22602470 0.93 FAAH (0.61) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL22589917 0.92 FAAH (0.70) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL30123722 0.91 FAAH (0.68) FAAHDGKAPRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712950-A2 IONIZABLE AMINE LIPIDS Intellia Therapeutics, Inc. (US) 2026-03-25 EP disclosed
WO-2024243031-A2 IONIZABLE AMINE LIPIDS INTELLIA THERAPEUTICS, INC. (US) 2024-11-28 WO disclosed